Masimo (NASDAQ:MASI) Lowered to “Market Perform” Rating by Raymond James Financial

Raymond James Financial lowered shares of Masimo (NASDAQ:MASI) from an outperform rating to a market perform rating in a report released on Friday morning, MarketBeat Ratings reports.

Several other research firms have also recently weighed in on MASI. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Finally, Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a research report on Tuesday, February 17th. Eight investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $181.17.

Masimo Price Performance

Shares of NASDAQ MASI opened at $177.11 on Friday. Masimo has a twelve month low of $125.94 and a twelve month high of $179.00. The stock’s 50 day moving average price is $159.93 and its 200-day moving average price is $148.32. The company has a market capitalization of $9.51 billion, a PE ratio of -16.80, a PEG ratio of 1.79 and a beta of 1.21. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72.

Institutional Trading of Masimo

A number of large investors have recently bought and sold shares of MASI. Jupiter Asset Management Ltd. bought a new position in Masimo during the third quarter worth about $12,491,000. American Century Companies Inc. raised its position in shares of Masimo by 10.6% in the third quarter. American Century Companies Inc. now owns 168,341 shares of the medical equipment provider’s stock valued at $24,839,000 after purchasing an additional 16,113 shares during the period. 4D Advisors LLC raised its position in shares of Masimo by 50.0% in the second quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $7,570,000 after purchasing an additional 15,000 shares during the period. ING Groep NV purchased a new stake in shares of Masimo during the 3rd quarter valued at approximately $3,069,000. Finally, Citigroup Inc. lifted its stake in shares of Masimo by 133.5% during the 3rd quarter. Citigroup Inc. now owns 116,672 shares of the medical equipment provider’s stock valued at $17,215,000 after buying an additional 66,710 shares in the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.